About this item
Product details
Glem-Lin 25 mg/5 mg from Nabiqasim is a powerful combination medication for managing Type 2 Diabetes. Each tablet contains 25 mg of Empagliflozin, an SGLT2 inhibitor, and 5 mg of Linagliptin, a DPP-4 inhibitor. This dual-mechanism approach provides comprehensive blood sugar control by helping your body remove excess glucose through urine while also increasing insulin production and decreasing sugar production in the liver. The 25 mg strength of Empagliflozin offers robust efficacy in a convenient once-daily tablet. Dual-Action Formula: Combines two complementary mechanisms for enhanced blood sugar control Comprehensive Glucose Management: Empagliflozin removes excess sugar through urine while Linagliptin improves your body's natural insulin response Cardiovascular Protection: Empagliflozin has demonstrated benefits in reducing cardiovascular risk in patients with Type 2 Diabetes Kidney Function Support: Helps protect kidney function and slow progression of kidney disease Composition Each film coated tablet contains: Empagliflozin : 25 mg Linagliptin: 5 mg Suggested Usage As directed by the physician
- Medicines
- 14 Film Coated Tablets
- 1 variant
- Protected Dastak checkout
Know before you buy
Specifications
- Department
- Health
- Subcategory
- Medicines
- Brand
- Nabiqasim
- SKU
- 08964003524111
- Variant
- 14 Film Coated Tablets
- Tags
- Empagliflozin, Linagliptin, Medicine
- Condition
- New
Customer feedback
Ratings & reviews
For help with a purchase, open your orders or contact Dastak support.
